GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Incanthera PLC (AQSE:INC) » Definitions » Long-Term Debt

Incanthera (AQSE:INC) Long-Term Debt : £0.20 Mil (As of Sep. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Incanthera Long-Term Debt?

Incanthera's Long-Term Debt for the quarter that ended in Sep. 2023 was £0.20 Mil.

Incanthera's quarterly Long-Term Debt increased from Sep. 2022 (£0.00 Mil) to Mar. 2023 (£0.13 Mil) and increased from Mar. 2023 (£0.13 Mil) to Sep. 2023 (£0.20 Mil).

Incanthera's annual Long-Term Debt stayed the same from Mar. 2021 (£0.00 Mil) to Mar. 2022 (£0.00 Mil) but then increased from Mar. 2022 (£0.00 Mil) to Mar. 2023 (£0.13 Mil).


Incanthera Long-Term Debt Historical Data

The historical data trend for Incanthera's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Incanthera Long-Term Debt Chart

Incanthera Annual Data
Trend Mar20 Mar21 Mar22 Mar23
Long-Term Debt
- - - 0.13

Incanthera Semi-Annual Data
Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Long-Term Debt Get a 7-Day Free Trial - - - 0.13 0.20

Incanthera  (AQSE:INC) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.


Incanthera Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Incanthera's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Incanthera (AQSE:INC) Business Description

Traded in Other Exchanges
N/A
Address
76 King Street, Manchester, GBR, M2 4NH
Incanthera PLC is a specialist dermatology and oncology company focused on transforming cancer treatment by creating environments in which cancer cannot survive. It identifies and develops solutions to current clinical, commercially relevant unmet needs, utilising a new technology. The company's current products are Sol, EP0015, Equin and Duo-C. The company has one segment, namely the development of pharmaceutical products all within the United Kingdom.

Incanthera (AQSE:INC) Headlines

No Headlines